Probing a protein–protein interaction by in vitro evolution

In this study, we used in vitro protein evolution with ribosome and phage display to optimize the affinity of a human IL-13-neutralizing antibody, a therapeutic candidate for the treatment of asthma, >150-fold to 81 pM by using affinity-driven stringency selections. Simultaneously, the antibody potency to inhibit IL-13-dependent proliferation in a cell-based functional assay increased 345-fold to an IC50 of 229 pM. The panoply of different optimized sequences resulting from complementarity-determining region-targeted mutagenesis and error-prone PCR using ribosome display was contrasted with that of complementarity-determining region-targeted mutagenesis alone using phage display. The data highlight the advantage of the ribosome-display approach in identifying beneficial mutations across the entire sequence space. A comparison of mutation hotspots from in vitro protein evolution to knockout mutations from alanine scanning demonstrated that in vitro evolution selects the most appropriate positions for improvements in potency without mutating any of the key residues within the functional paratope.

[1]  Tristan J. Vaughan,et al.  Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.

[2]  G. Winter,et al.  Selection of phage antibodies by binding affinity. Mimicking affinity maturation. , 1992, Journal of molecular biology.

[3]  P. Schultz,et al.  Mutational analysis of the affinity maturation of antibody 48G7. , 1999, Journal of Molecular Biology.

[4]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[5]  Frances H. Arnold,et al.  Exploring Nonnatural Evolutionary Pathways by Saturation Mutagenesis: Rapid Improvement of Protein Function , 1999, Journal of Molecular Evolution.

[6]  R. Poljak,et al.  Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: a novel conformational change in antibody CDR-L3 selects for antigen. , 1996, Journal of molecular biology.

[7]  R. Kelley,et al.  Thermodynamic analysis of an antibody functional epitope. , 1993, Biochemistry.

[8]  R C Stevens,et al.  A comparative analysis of the immunological evolution of antibody 28B4. , 2001, Biochemistry.

[9]  Inger Sandlie,et al.  Therapeutic antibodies for human diseases at the dawn of the twenty-first century , 2003, Nature Reviews Drug Discovery.

[10]  Sachdev S Sidhu,et al.  Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. , 2002, Journal of molecular biology.

[11]  P. Carter,et al.  Sequence plasticity in the antigen-binding site of a therapeutic anti-HER2 antibody. , 2002, Journal of molecular biology.

[12]  A. Plückthun,et al.  Tailoring in vitro evolution for protein affinity or stability. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Andrew J. Martin,et al.  Antibody-antigen interactions: contact analysis and binding site topography. , 1996, Journal of molecular biology.

[14]  Peter G Schultz,et al.  Structural plasticity and the evolution of antibody affinity and specificity. , 2003, Journal of molecular biology.

[15]  P. T. Jones,et al.  The creation of diversity in the human immunoglobulin Vλ repertoire , 1997 .

[16]  A. Plückthun,et al.  Selecting and evolving functional proteins in vitro by ribosome display. , 2000, Methods in enzymology.

[17]  V. Roschke,et al.  Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. , 2003, Arthritis and rheumatism.

[18]  A R Rees,et al.  WAM: an improved algorithm for modelling antibodies on the WEB. , 2000, Protein engineering.

[19]  John A. Robinson,et al.  Analysis of Antibody A6 Binding to the Extracellular Interferon γ Receptor α-Chain by Alanine-Scanning Mutagenesis and Random Mutagenesis with Phage Display† , 2000 .

[20]  K D Wittrup,et al.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E L Sonnhammer,et al.  The imprint of somatic hypermutation on the repertoire of human germline V genes. , 1996, Journal of molecular biology.

[22]  J. Link,et al.  Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display , 1994, Applied biochemistry and biotechnology.

[23]  M. N. Margolies,et al.  Structural Analysis of Mutants of High-Affinity and Low-Affinity p-Azophenylarsonate-Specific Antibodies Generated by Alanine Scanning of Heavy Chain Complementarity-Determining Region 21 , 2001, The Journal of Immunology.

[24]  N S Greenspan,et al.  Complementarity, specificity and the nature of epitopes and paratopes in multivalent interactions. , 1995, Immunology today.

[25]  A. Cattaneo,et al.  An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. , 1997, Gene.

[26]  J. C. Almagro,et al.  Analysis of antibodies of known structure suggests a lack of correspondence between the residues in contact with the antigen and those modified by somatic hypermutation , 2001, Proteins.

[27]  H. Carlson.  Protein flexibility and drug design: how to hit a moving target. , 2002, Current opinion in chemical biology.

[28]  R. Karlsson,et al.  Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. , 1991, Journal of immunological methods.